Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT05248737

Bioavailability of Vitamin D(25(OH)D) and Omega-3 Fatty Acid (DHA) Enhanced Chicken

Empowering and Transforming the US Broiler Production for Growth, Profit and Sustainability

Status
Active Not Recruiting
Phase
Study type
Observational
Enrollment
84 (estimated)
Sponsor
Cornell University · Academic / Other
Sex
All
Age
18 Years – 35 Years
Healthy volunteers
Accepted

Summary

The purpose of the research is to evaluate if chicken or eggs obtained from chickens that are fed a diet that contains omega-3 fatty acids (DHA/EPA), or vitamin D (as 25(OH)D) provides additional health benefits by improving the status of omega-3 fatty acids or 25(OH)D in healthy adults who eat this bioenhanced chicken or eggs.

Detailed description

The 2015-2020 Dietary Guidelines advocate intake of lean proteins (such as chicken and fish) while limiting intake of saturated fat. Chicken contains similar protein to beef or pork but has less saturated fat. However, chicken, like other terrestrial meats, has little omega-3 polyunsaturated fatty acids such as docosahexaenoic acid (DHA) or eicosapentaenoic acid (EPA) and relatively little vitamin D. Vitamin D insufficiency is common in the US and globally, and has been linked to a number of adverse health outcomes. Vitamin D is ingested primarily from fortified dairy products, but recent animal studies have increased the D content of pork and beef, and the DHA content of chicken and of eggs produced from bioenhanced chickens. Moreover, sunlight exposure alone can enhance the 25(OH)D content of chicken. Notably, supplemental 25(OH)D is more effective than vitamin D at improving vitamin D status in humans, but little is known about the bioavailability of 25(OH)D or DHA/EPA enhanced chicken (muscle) or in enhanced eggs produced from supplemented chickens.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTDHA/EPA fortified chicken plus PlaceboFor participants who received DHA/EPA fortified chicken
DIETARY_SUPPLEMENTnon-25(OH)D fortified chicken/eggs plus vitamin D3 supplementProvided to participants in the group where they consumed non-fortified chicken/eggs
DIETARY_SUPPLEMENTnon-DHA bio-enhanced chicken plus supplement DHA Omega-3Used in the crossover part of the study given to the group who did not received DHA bio-enhanced chicken
DIETARY_SUPPLEMENT25(OH)D bioenhanced chicken and eggs plus placeboparticipants will receive 25(OH)D bioenhanced chicken and eggs plus a placebo as a dietary intervention
DIETARY_SUPPLEMENTDietary Supplement: DHA/EPA fortified eggs plus PlaceboFor the participants who received DHA/EPA fortified eggs
DIETARY_SUPPLEMENTnon-DHA bio-enhanced eggs plus supplement DHA Omega-3for the participants who received non-DHA bio-enhanced eggs plus supplement DHA Omega-3
OTHERnon-25(OH)D fortified chicken/eggs plus placeboProvided to participants in the group where they consumed non-fortified chicken/eggs + placebo pills

Timeline

Start date
2021-12-04
Primary completion
2024-12-11
Completion
2026-05-30
First posted
2022-02-21
Last updated
2026-04-01

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05248737. Inclusion in this directory is not an endorsement.